FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Eva Tzelepi

Research Profile

Chemicals & Drugs

Procedures

Geographic Areas

Greece

Living Beings

Physiology

Concepts & Ideas

Molecular Sequence Data

Disorders

Klebsiella Infections

Co-author Network

Publications

TOP 3
Constantinos C Papagiannitsis; Olga Pappa; M Polemis; Kyriaki Tryfinopoulou; Eva Tzelepi; Leonidas S Tzouvelekis; Panagiota Giakkoupi; Alkiviadis Vatopoulos
Diversity of acquired β-lactamases amongst Klebsiella pneumoniae in Greek hospitals.
Angeliki Mavroidi; Vivi Miriagou; George N Dalekos; Apostolos Liakopoulos; Angelos Stefos; Eva Tzelepi; Efi Petinaki
Ciprofloxacin-resistant Escherichia coli in Central Greece: mechanisms of resistance and molecular identification.
Stathis D Kotsakis; Efthymia Petinaki; Eva Tzelepi; Leonidas S Tzouvelekis; Vivi Miriagou
Effects of the Val211Gly substitution on molecular dynamics of the CMY-2 cephalosporinase: implications on hydrolysis of expanded-spectrum cephalosporins.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Eva Tzelepi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Constantinos C Papagiannitsis; Olga Pappa; M Polemis; Kyriaki Tryfinopoulou; Eva Tzelepi; Leonidas S Tzouvelekis; Panagiota Giakkoupi; Alkiviadis Vatopoulos
Diversity of acquired β-lactamases amongst Klebsiella pneumoniae in Greek hospitals.
International journal of antimicrobial agents 2012;39(2):178-80.
2012: Angeliki Mavroidi; Vivi Miriagou; George N Dalekos; Apostolos Liakopoulos; Angelos Stefos; Eva Tzelepi; Efi Petinaki
Ciprofloxacin-resistant Escherichia coli in Central Greece: mechanisms of resistance and molecular identification.
BMC infectious diseases 2012;12():371.
2011: Stathis D Kotsakis; Efthymia Petinaki; Eva Tzelepi; Leonidas S Tzouvelekis; Vivi Miriagou
Effects of the Val211Gly substitution on molecular dynamics of the CMY-2 cephalosporinase: implications on hydrolysis of expanded-spectrum cephalosporins.
Proteins 2011;79(11):3180-92.
2011: C C Papagiannitsis; Efi Petinaki; Eva Tzelepi; S D Kotsakis; Vivi Miriagou; Alkiviadis Vatopoulos; Leonidas S Tzouvelekis
Characterization of metallo-beta-lactamase VIM-27, an A57S mutant of VIM-1 associated with Klebsiella pneumoniae ST147.
Antimicrobial agents and chemotherapy 2011;55(7):3570-2.
2011: Angeliki Mavroidi; Eva Tzelepi; Eirini Siatravani; Daniel Godoy; Vivi Miriagou; Brian G Spratt
Analysis of emergence of quinolone-resistant gonococci in Greece by combined use of Neisseria gonorrhoeae multiantigen sequence typing and multilocus sequence typing.
Journal of clinical microbiology 2011;49(4):1196-201.
2011: C C Papagiannitsis; Leonidas S Tzouvelekis; S D Kotsakis; Eva Tzelepi; Vivi Miriagou
Sequence of pR3521, an IncB plasmid from Escherichia coli encoding ACC-4, SCO-1, and TEM-1 beta-lactamases.
Antimicrobial agents and chemotherapy 2011;55(1):376-81.
2010: Stathis D Kotsakis; Vivi Miriagou; Eva Tzelepi; Leonidas S Tzouvelekis
Comparative biochemical and computational study of the role of naturally occurring mutations at Ambler positions 104 and 170 in GES β-lactamases.
Antimicrobial agents and chemotherapy 2010;54(11):4864-71.
2010: Vivi Miriagou; C C Papagiannitsis; S D Kotsakis; A Loli; Eva Tzelepi; Nicholas J Legakis; Leonidas S Tzouvelekis
Sequence of pNL194, a 79.3-kilobase IncN plasmid carrying the blaVIM-1 metallo-beta-lactamase gene in Klebsiella pneumoniae.
Antimicrobial agents and chemotherapy 2010;54(10):4497-502.
2010: A Zioga; Vivi Miriagou; Eva Tzelepi; E Douzinas; M Tsakiri; Nicholas J Legakis; G L Daikos; Leonidas S Tzouvelekis
The ongoing challenge of acquired carbapenemases: a hospital outbreak of Klebsiella pneumoniae simultaneously producing VIM-1 and KPC-2.
International journal of antimicrobial agents 2010;36(2):190-1.
2010: S D Kotsakis; C C Papagiannitsis; Eva Tzelepi; Nicholas J Legakis; Vivi Miriagou; Leonidas S Tzouvelekis
GES-13, a beta-lactamase variant possessing Lys-104 and Asn-170 in Pseudomonas aeruginosa.
Antimicrobial agents and chemotherapy 2010;54(3):1331-3.
2010: Eva Tzelepi; Helen Avgerinou; Alexandros Flemetakis; Eirini Siatravani; Maria Stathi; Maria Daniilidou; Vivi Miriagou
Changing figures of antimicrobial susceptibility and serovar distribution in Neisseria gonorrhoeae isolated in Greece.
Sexually transmitted diseases 2010;37(2):115-20.
2009: Stathis D Kotsakis; Costas C Papagiannitsis; Eva Tzelepi; Leonidas S Tzouvelekis; Vivi Miriagou
Extended-spectrum properties of CMY-30, a Val211Gly mutant of CMY-2 cephalosporinase.
Antimicrobial agents and chemotherapy 2009;53(8):3520-3.
2009: A Zioga; Jean M Whichard; S D Kotsakis; Leonidas S Tzouvelekis; Eva Tzelepi; Vivi Miriagou
CMY-31 and CMY-36 cephalosporinases encoded by ColE1-like plasmids.
Antimicrobial agents and chemotherapy 2009;53(3):1256-9.
2008: Eva Tzelepi; Maria Daniilidou; Vivi Miriagou; Eirini Siatravani; Efthimia Pavlidou; Alexandros Flemetakis
Cluster of multidrug-resistant Neisseria gonorrhoeae with reduced susceptibility to the newer cephalosporins in Northern Greece.
The Journal of antimicrobial chemotherapy 2008;62(3):637-9.
2008: Alexandra Loli; Leonidas S Tzouvelekis; Dimitra Gianneli; Eva Tzelepi; Vivi Miriagou
Outbreak of Acinetobacter baumannii with chromosomally encoded VIM-1 undetectable by imipenem-EDTA synergy tests.
Antimicrobial agents and chemotherapy 2008;52(5):1894-6.
2007: Costas C Papagiannitsis; Leonidas S Tzouvelekis; Eva Tzelepi; Vivi Miriagou
Plasmid-encoded ACC-4, an extended-spectrum cephalosporinase variant from Escherichia coli.
Antimicrobial agents and chemotherapy 2007;51(10):3763-7.
2007: C C Papagiannitsis; Alexandra Loli; Leonidas S Tzouvelekis; Eva Tzelepi; G Arlet; Vivi Miriagou
SCO-1, a novel plasmid-mediated class A beta-lactamase with carbenicillinase characteristics from Escherichia coli.
Antimicrobial agents and chemotherapy 2007;51(6):2185-8.
2007: A Panagiotakopoulou; George L Daikos; Vivi Miriagou; Alexandra Loli; Eva Tzelepi; Leonidas S Tzouvelekis
Comparative in vitro killing of carbapenems and aztreonam against Klebsiella pneumoniae producing VIM-1 metallo-beta-lactamase.
International journal of antimicrobial agents 2007;29(3):360-2.
2007: George L Daikos; A Panagiotakopoulou; Eva Tzelepi; Alexandra Loli; Leonidas S Tzouvelekis; Vivi Miriagou
Activity of imipenem against VIM-1 metallo-beta-lactamase-producing Klebsiella pneumoniae in the murine thigh infection model.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2007;13(2):202-5.
2006: Alexandra Loli; Leonidas S Tzouvelekis; Eva Tzelepi; Alessandra Carattoli; Alkiviadis Vatopoulos; Panayotis Tassios; Vivi Miriagou
Sources of diversity of carbapenem resistance levels in Klebsiella pneumoniae carrying blaVIM-1.
The Journal of antimicrobial chemotherapy 2006;58(3):669-72.
2006: Maria Stathi; Alexandros Flemetakis; Vivi Miriagou; Helen Avgerinou; Kyriakos P Kyriakis; Antonios N Maniatis; Eva Tzelepi
Antimicrobial susceptibility of Neisseria gonorrhoeae in Greece: data for the years 1994-2004.
The Journal of antimicrobial chemotherapy 2006;57(4):775-9.
2005: Vivi Miriagou; Alessandra Carattoli; Eva Tzelepi; Laura Villa; Leonidas S Tzouvelekis
IS26-associated In4-type integrons forming multiresistance loci in enterobacterial plasmids.
Antimicrobial agents and chemotherapy 2005;49(8):3541-3.
2005: Vivi Miriagou; Eva Tzelepi; George L Daikos; Panayotis Tassios; Leonidas S Tzouvelekis
Panresistance in VIM-1-producing Klebsiella pneumoniae.
The Journal of antimicrobial chemotherapy 2005;55(5):810-1.
2005: Joseph GANGOUE-PIEBOJI; Vivi Miriagou; Sofia Vourli; Eva Tzelepi; Pierre Ngassam; Leonidas S Tzouvelekis
Emergence of CTX-M-15-producing enterobacteria in Cameroon and characterization of a blaCTX-M-15-carrying element.
Antimicrobial agents and chemotherapy 2005;49(1):441-3.
2004: Vivi Miriagou; Leonidas S Tzouvelekis; Laura Villa; Evangelia Lebessi; Alkiviadis Vatopoulos; Alessandra Carattoli; Eva Tzelepi
CMY-13, a novel inducible cephalosporinase encoded by an Escherichia coli plasmid.
Antimicrobial agents and chemotherapy 2004;48(8):3172-4.
2004: Sofia Vourli; Panagiota Giakkoupi; Vivi Miriagou; Eva Tzelepi; Alkiviadis Vatopoulos; Leonidas S Tzouvelekis
Novel GES/IBC extended-spectrum beta-lactamase variants with carbapenemase activity in clinical enterobacteria.
FEMS microbiology letters 2004;234(2):209-13.
2003: Sofia Vourli; Leonidas S Tzouvelekis; Eva Tzelepi; Evangelia Lebessi; Nicholas J Legakis; Vivi Miriagou
Characterization of In111, a class 1 integron that carries the extended-spectrum beta-lactamase gene blaIBC-1.
FEMS microbiology letters 2003;225(1):149-53.
2003: Sofia Vourli; Leonidas S Tzouvelekis; Eva Tzelepi; G Kartali; C Kontopoulou; Danai Sofianou; L S Tzouvelekis
Characterization of Klebsiella pneumoniae clinical strains producing a rare extended-spectrum beta-lactamase (IBC-1).
International journal of antimicrobial agents 2003;21(5):495-7.
2003: Vivi Miriagou; Leonidas S Tzouvelekis; Shannon Rossiter; Eva Tzelepi; Frederick J Angulo; Jean M Whichard
Imipenem resistance in a Salmonella clinical strain due to plasmid-mediated class A carbapenemase KPC-2.
Antimicrobial agents and chemotherapy 2003;47(4):1297-300.
2003: Eva Tzelepi; Ch Magana; Evangelia Platsouka; Danai Sofianou; Olga Paniara; Nicholas J Legakis; Alkiviadis Vatopoulos; Leonidas S Tzouvelekis
Extended-spectrum beta-lactamase types in Klebsiella pneumoniae and Escherichia coli in two Greek hospitals.
International journal of antimicrobial agents 2003;21(3):285-8.
2003: Vivi Miriagou; Eva Tzelepi; Dimitra Gianneli; Leonidas S Tzouvelekis
Escherichia coli with a self-transferable, multiresistant plasmid coding for metallo-beta-lactamase VIM-1.
Antimicrobial agents and chemotherapy 2003;47(1):395-7.
2002: Georgia Kartali; Eva Tzelepi; Spyros Pournaras; Constantina Kontopoulou; Fanourios Kontos; Danai Sofianou; Antonios N Maniatis; Athanassios Tsakris
Outbreak of infections caused by Enterobacter cloacae producing the integron-associated beta-lactamase IBC-1 in a neonatal intensive care unit of a Greek hospital.
Antimicrobial agents and chemotherapy 2002;46(5):1577-80.
2002: Angeliki Mavroidi; Eva Tzelepi; Vivi Miriagou; D Gianneli; Nicholas J Legakis; Leonidas S Tzouvelekis
CTX-m-3 beta-lactamase-producing Escherichia coli from Greece.
Microbial drug resistance (Larchmont, N.Y.) 2002;8(1):35-7.
2001: Angeliki Mavroidi; Eva Tzelepi; Athanassios Tsakris; Vivi Miriagou; Danai Sofianou; Leonidas S Tzouvelekis
An integron-associated beta-lactamase (IBC-2) from Pseudomonas aeruginosa is a variant of the extended-spectrum beta-lactamase IBC-1.
The Journal of antimicrobial chemotherapy 2001;48(5):627-30.
2001: Angeliki Mavroidi; Leonidas S Tzouvelekis; Kyriakos P Kyriakis; Helen Avgerinou; M Daniilidou; Eva Tzelepi
Multidrug-resistant strains of Neisseria gonorrhoeae in Greece.
Antimicrobial agents and chemotherapy 2001;45(9):2651-4.
2001: Panagiota Giakkoupi; Andrea Hujer; Vivi Miriagou; Eva Tzelepi; R A Bonomo; Leonidas S Tzouvelekis
Substitution of Thr for Ala-237 in TEM-17, TEM-12 and TEM-26: alterations in beta-lactam resistance conferred on Escherichia coli.
FEMS microbiology letters 2001;201(1):37-40.
2000: Angeliki Mavroidi; Athanassios Tsakris; Eva Tzelepi; Spyros Pournaras; V Loukova; Leonidas S Tzouvelekis
Carbapenem-hydrolysing VIM-2 metallo- beta-lactamase in Pseudomonas aeruginosa from Greece.
The Journal of antimicrobial chemotherapy 2000;46(6):1041-2.
2000: Eva Tzelepi; Malamatenia Arvanitidou; Leonidas S Tzouvelekis; Angeliki Mavroidi; Athanassios Tsakris
The isoelectric focusing patterns of beta-lactamases of Yersinia intermedia isolates from aquatic environments.
The Journal of antimicrobial chemotherapy 2000;46(3):513-5.
2000: Angeliki Mavroidi; Leonidas S Tzouvelekis; Panayotis Tassios; Alexandros Flemetakis; M Daniilidou; Eva Tzelepi
Characterization of Neisseria gonorrhoeae strains with decreased susceptibility to fluoroquinolones isolated in Greece from 1996 to 1999.
Journal of clinical microbiology 2000;38(9):3489-91.
2000: Panagiota Giakkoupi; Leonidas S Tzouvelekis; Athanassios Tsakris; V Loukova; Danai Sofianou; Eva Tzelepi
IBC-1, a novel integron-associated class A beta-lactamase with extended-spectrum properties produced by an Enterobacter cloacae clinical strain.
Antimicrobial agents and chemotherapy 2000;44(9):2247-53.
2000: Evangelia Platsouka; H Dimopoulou; Eva Tzelepi; Vivi Miriagou; Leonidas S Tzouvelekis
Diversity of beta-lactam resistance levels among related Klebsiella pneumoniae strains isolated in an intensive care unit.
Journal of chemotherapy (Florence, Italy) 2000;12(3):204-7.
2000: Leonidas S Tzouvelekis; Eva Tzelepi; Panayotis Tassios; Nicholas J Legakis
CTX-M-type beta-lactamases: an emerging group of extended-spectrum enzymes.
International journal of antimicrobial agents 2000;14(2):137-42.
2000: Eva Tzelepi; Panagiota Giakkoupi; Danai Sofianou; V Loukova; A Kemeroglou; Athanassios Tsakris
Detection of extended-spectrum beta-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes.
Journal of clinical microbiology 2000;38(2):542-6.
2000: Panagiota Giakkoupi; Eva Tzelepi; Panayotis Tassios; Nicholas J Legakis; Leonidas S Tzouvelekis
Detrimental effect of the combination of R164S with G238S in TEM-1 beta-lactamase on the extended-spectrum activity conferred by each single mutation.
The Journal of antimicrobial chemotherapy 2000;45(1):101-4.
1999: Panayotis Tassios; Maria Gazouli; Eva Tzelepi; H Milch; NS Kozlova; S Sidorenko; Nicholas J Legakis; Leonidas S Tzouvelekis
Spread of a Salmonella typhimurium clone resistant to expanded-spectrum cephalosporins in three European countries.
Journal of clinical microbiology 1999;37(11):3774-7.
1999: Leonidas S Tzouvelekis; Alkiviadis Vatopoulos; G Katsanis; Eva Tzelepi
Rare case of failure by an automated system to detect extended-spectrum beta-lactamase in a cephalosporin-resistant Klebsiella pneumoniae isolate.
Journal of clinical microbiology 1999;37(7):2388.
1999: Eva Tzelepi; G Kouppari; Angeliki Mavroidi; A Zaphiropoulou; Leonidas S Tzouvelekis
Erythromycin resistance amongst group A beta-haemolytic streptococci isolated in a paediatric hospital in Athens, Greece.
The Journal of antimicrobial chemotherapy 1999;43(5):745-6.
1999: Eva Tzelepi; Malamatenia Arvanitidou; Angeliki Mavroidi; Athanassios Tsakris
Antibiotic susceptibilities of Yersinia enterocolitica and Y. intermedia isolates from aquatic environments.
Journal of medical microbiology 1999;48(2):157-60.
1999: Panagiota Giakkoupi; Eva Tzelepi; Nicholas J Legakis; Leonidas S Tzouvelekis
Aspartic acid for asparagine substitution at position 276 reduces susceptibility to mechanism-based inhibitors in SHV-1 and SHV-5 beta-lactamases.
The Journal of antimicrobial chemotherapy 1999;43(1):23-9.
1999: Kyriakos P Kyriakis; Eva Tzelepi; Alexandros Flemetakis; Helen Avgerinou; Leonidas S Tzouvelekis; E Frangouli
Epidemiologic aspects of male gonococcal infection in Greece.
Sexually transmitted diseases 1999;26(1):43-8.
1998: Maria Gazouli; Leonidas S Tzouvelekis; Alkiviadis Vatopoulos; Eva Tzelepi
Transferable class C beta-lactamases in Escherichia coli strains isolated in Greek hospitals and characterization of two enzyme variants (LAT-3 and LAT-4) closely related to Citrobacter freundii AmpC beta-lactamase.
The Journal of antimicrobial chemotherapy 1998;42(4):419-25.
1998: Maria Gazouli; Eva Tzelepi; Antonios Markogiannakis; Nicholas J Legakis; Leonidas S Tzouvelekis
Two novel plasmid-mediated cefotaxime-hydrolyzing beta-lactamases (CTX-M-5 and CTX-M-6) from Salmonella typhimurium.
FEMS microbiology letters 1998;165(2):289-93.
1998: Leonidas S Tzouvelekis; Maria Gazouli; Antonios Markogiannakis; E Paraskaki; Nicholas J Legakis; Eva Tzelepi
Emergence of resistance to third-generation cephalosporins amongst Salmonella typhimurium isolates in Greece: report of the first three cases.
The Journal of antimicrobial chemotherapy 1998;42(2):273-5.
1998: Panagiota Giakkoupi; Vivi Miriagou; Maria Gazouli; Eva Tzelepi; Nicholas J Legakis; Leonidas S Tzouvelekis
Properties of mutant SHV-5 beta-lactamases constructed by substitution of isoleucine or valine for methionine at position 69.
Antimicrobial agents and chemotherapy 1998;42(5):1281-3.
1998: Maria Gazouli; Eva Tzelepi; S V Sidorenko; Leonidas S Tzouvelekis
Sequence of the gene encoding a plasmid-mediated cefotaxime-hydrolyzing class A beta-lactamase (CTX-M-4): involvement of serine 237 in cephalosporin hydrolysis.
Antimicrobial agents and chemotherapy 1998;42(5):1259-62.
1998: Panagiota Giakkoupi; Eva Tzelepi; Nicholas J Legakis; Leonidas S Tzouvelekis
Substitution of Arg-244 by Cys or Ser in SHV-1 and SHV-5 beta-lactamases confers resistance to mechanism-based inhibitors and reduces catalytic efficiency of the enzymes.
FEMS microbiology letters 1998;160(1):49-54.
1998: Maria Gazouli; S V Sidorenko; Eva Tzelepi; NS Kozlova; DP Gladin; Leonidas S Tzouvelekis
A plasmid-mediated beta-lactamase conferring resistance to cefotaxime in a Salmonella typhimurium clone found in St Petersburg, Russia.
The Journal of antimicrobial chemotherapy 1998;41(1):119-21.
1998: Leonidas S Tzouvelekis; Eva Tzelepi; EE Prinarakis; Maria Gazouli; A Katrahoura; Panagiota Giakkoupi; Olga Paniara; Nicholas J Legakis
Sporadic emergence of Klebsiella pneumoniae strains resistant to cefepime and cefpirome in Greek hospitals.
Journal of clinical microbiology 1998;36(1):266-8.
1997: Eva Tzelepi; Helen Avgerinou; Kyriakos P Kyriakis; Leonidas S Tzouvelekis; Alexandros Flemetakis; A Kalogeropoulou; E Frangouli
Antimicrobial susceptibility and types of Neisseria gonorrhoeae in Greece. Data for the period 1990 to 1993.
Sexually transmitted diseases 1997;24(6):378-85.
1997: EE Prinarakis; Vivi Miriagou; Eva Tzelepi; Maria Gazouli; Leonidas S Tzouvelekis
Emergence of an inhibitor-resistant beta-lactamase (SHV-10) derived from an SHV-5 variant.
Antimicrobial agents and chemotherapy 1997;41(4):838-40.
1997: Leonidas S Tzouvelekis; Maria Gazouli; EE Prinarakis; Eva Tzelepi; Nicholas J Legakis
Comparative evaluation of the inhibitory activities of the novel penicillanic acid sulfone Ro 48-1220 against beta-lactamases that belong to groups 1, 2b, and 2be.
Antimicrobial agents and chemotherapy 1997;41(2):475-7.
1997: Maria Gazouli; Mary E Kaufmann; Eva Tzelepi; H Dimopoulou; Olga Paniara; Leonidas S Tzouvelekis
Study of an outbreak of cefoxitin-resistant Klebsiella pneumoniae in a general hospital.
Journal of clinical microbiology 1997;35(2):508-10.
1997: Leonidas S Tzouvelekis; N P Zissis; Maria Gazouli; Eva Tzelepi; Nicholas J Legakis
In vitro comparative assessment of beta-lactamase inhibitors and their penicillin combinations against selected enterobacteria.
International journal of antimicrobial agents 1997;8(3):193-7.
1996: S D Georgopoulos; A F Mentis; C A Spiliadis; Leonidas S Tzouvelekis; Eva Tzelepi; A Moshopoulos; Nikolaos Skandalis
Helicobacter pylori infection in spouses of patients with duodenal ulcers and comparison of ribosomal RNA gene patterns.
Gut 1996;39(5):634-8.
1996: Leonidas S Tzouvelekis; EE Prinarakis; M Gazouli; Vivi Miriagou; Eva Tzelepi; Nicholas J Legakis
In vitro activity of cefetamet against enterobacteria expressing an SHV-5-type beta-lactamase.
Chemotherapy 1996;42(5):324-8.
1996: M Gazouli; Leonidas S Tzouvelekis; EE Prinarakis; Vivi Miriagou; Eva Tzelepi
Transferable cefoxitin resistance in enterobacteria from Greek hospitals and characterization of a plasmid-mediated group 1 beta-lactamase (LAT-2).
Antimicrobial agents and chemotherapy 1996;40(7):1736-40.
1996: EE Prinarakis; Eva Tzelepi; M Gazouli; A F Mentis; Leonidas S Tzouvelekis
Characterization of a novel SHV beta-lactamase variant that resembles the SHV-5 enzyme.
FEMS microbiology letters 1996;139(2-3):229-34.
1995: Leonidas S Tzouvelekis; Eva Tzelepi; A F Mentis; Nicholas J Legakis
In vitro activity of cefpirome against selected clinical enterobacterial isolates with beta-lactamase-mediated resistance.
Infection 1995;23(6):384-7.
1995: Nicholas J Legakis; Leonidas S Tzouvelekis; G Hatzoudis; Eva Tzelepi; A Gourkou; Tyrone L Pitt; Alkiviadis Vatopoulos
Klebsiella pneumoniae infections in Greek hospitals. Dissemination of plasmids encoding an SHV-5 type beta-lactamase.
The Journal of hospital infection 1995;31(3):177-87.
1994: D Gianneli; Eva Tzelepi; Leonidas S Tzouvelekis; A F Mentis; C Nikolopoulou
Dissemination of cephalosporin-resistant Serratia marcescens strains producing a plasmidic SHV type beta-lactamase in Greek hospitals.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1994;13(9):764-7.
1994: Leonidas S Tzouvelekis; Eva Tzelepi; A F Mentis
Nucleotide sequence of a plasmid-mediated cephalosporinase gene (blaLAT-1) found in Klebsiella pneumoniae.
Antimicrobial agents and chemotherapy 1994;38(9):2207-9.
1994: Leonidas S Tzouvelekis; Eva Tzelepi; Mary E Kaufmann; A F Mentis
Consecutive mutations leading to the emergence in vivo of imipenem resistance in a clinical strain of Enterobacter aerogenes.
Journal of medical microbiology 1994;40(6):403-7.
1993: Leonidas S Tzouvelekis; Eva Tzelepi; A F Mentis; Athanassios Tsakris
Identification of a novel plasmid-mediated beta-lactamase with chromosomal cephalosporinase characteristics from Klebsiella pneumoniae.
The Journal of antimicrobial chemotherapy 1993;31(5):645-54.
1992: Leonidas S Tzouvelekis; Eva Tzelepi; A F Mentis; Alkiviadis Vatopoulos; Athanassios Tsakris
Imipenem resistance in Enterobacter aerogenes is associated with derepression of chromosomal cephalosporinases and impaired permeability.
FEMS microbiology letters 1992;74(2-3):195-9.
1992: Eva Tzelepi; Leonidas S Tzouvelekis; Alkiviadis Vatopoulos; A F Mentis; Athanassios Tsakris; Nicholas J Legakis
High prevalence of stably derepressed class-I beta-lactamase expression in multiresistant clinical isolates of Enterobacter cloacae from Greek hospitals.
Journal of medical microbiology 1992;37(2):91-5.
1991: Eva Tzelepi; E Fragouli; V Athanassopoulou; G Tzanakaki; P Tseliou
Neisseria gonorrhoeae in Athens, Greece. Epidemiologic classification and antimicrobial susceptibility patterns of strains isolated between 1986 and 1989.
Sexually transmitted diseases 1991;18(4):238-44.
1989: G Tzanakaki; L Mavrommati; Eva Tzelepi; S Kolyva; E Fragouli
Serological classification in relation to auxotypes, plasmid contents, and susceptibilities to antimicrobials of PPNG and non-PPNG strains isolated in Greece.
Genitourinary medicine 1989;65(3):171-6.
1989: L Mavrommati; Eva Tzelepi
Conjugal transfer of penicillin resistance plasmids to proline-citrulline-uracil dependent strains of Neisseria gonorrhoeae.
The Journal of antimicrobial chemotherapy 1989;23(3):335-9.
1988: L Mavrommati; Eva Tzelepi; A Sima; G Tzanakaki; A Kokla; Alexandros Flemetakis
Antibiotic resistance, plasmid content and auxotypes of Neisseria gonorrhoeae in Greece.
The Journal of antimicrobial chemotherapy 1988;21(5):571-9.